Whilst price cut cards can help ease the load of large drug fees in the short-term, they don't deal with the systemic concerns driving up prescription price ranges during the U.S. Broader policy adjustments could tackle the basis brings about of soaring drug charges, like lack of transparency in pricing and also the job of intermediaries like PBMs.